Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
An experimental compound shrank lung-cancer tumors in half of the patients in a recent study.
A startup says its test can distinguish between subtypes of lung cancer.
Researchers look beyond genetics to discover what makes some lung cancer patients respond to certain drugs.
New diagnosis methods could reduce invasive and unnecessary surgery.